Friday, October 05, 2012 8:12:42 AM
Accuray Incorporated to Host Investor Meeting at ASTRO 2012
PR NewswirePress Release: Accuray Incorporated – Mon, Oct 1, 2012 8:30 AM EDT
SUNNYVALE, Calif., Oct. 1, 2012 /PRNewswire/ -- Accuray Incorporated (ARAY), the premier radiation oncology company, announced today that it will host an investor meeting on Monday, October 29, 2012 at the annual meeting of the American Society for Radiation Oncology (ASTRO) being held in Boston. The meeting is open to institutional investors and research analysts.
Accuray's management will host a breakfast meeting, from 7:30 a.m. to 9:30 a.m. E.D.T. on Monday, October 29 at the Renaissance Boston Waterfront Hotel, 606 Congress Street Boston, in the Pacific Ballroom, Salon A-C. The presentation will provide a review of Accuray's new technology platforms that will be introduced at ASTRO. Investors who are attending the trade show are encouraged to visit the Accuray booth #7101.
Attendees are asked to register no later than Friday, October 19 from our event website: http://www.cvent.com/d/bcqxrm.
A live webcast of the presentation will be available online from the investor relations section of the company website at www.accuray.com/investors. The webcast replay of the presentation will begin approximately one hour after the conclusion of the live presentation and will be available for approximately 30 days.
About Accuray
Accuray Incorporated (ARAY), based in Sunnyvale, Calif., is the premier radiation oncology company that develops, manufactures and sells personalized, innovative treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The Company's leading-edge technologies – the CyberKnife and TomoTherapy Systems – are designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, and adaptive radiation therapy. To date, 642 systems have been installed in leading hospitals around the world. For more information, please visit www.accuray.com.
Available Topic Expert: For information on the listed expert, click appropriate link.
Euan Thomson, Ph.D.
ProfNet - https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=81869
PR NewswirePress Release: Accuray Incorporated – Mon, Oct 1, 2012 8:30 AM EDT
SUNNYVALE, Calif., Oct. 1, 2012 /PRNewswire/ -- Accuray Incorporated (ARAY), the premier radiation oncology company, announced today that it will host an investor meeting on Monday, October 29, 2012 at the annual meeting of the American Society for Radiation Oncology (ASTRO) being held in Boston. The meeting is open to institutional investors and research analysts.
Accuray's management will host a breakfast meeting, from 7:30 a.m. to 9:30 a.m. E.D.T. on Monday, October 29 at the Renaissance Boston Waterfront Hotel, 606 Congress Street Boston, in the Pacific Ballroom, Salon A-C. The presentation will provide a review of Accuray's new technology platforms that will be introduced at ASTRO. Investors who are attending the trade show are encouraged to visit the Accuray booth #7101.
Attendees are asked to register no later than Friday, October 19 from our event website: http://www.cvent.com/d/bcqxrm.
A live webcast of the presentation will be available online from the investor relations section of the company website at www.accuray.com/investors. The webcast replay of the presentation will begin approximately one hour after the conclusion of the live presentation and will be available for approximately 30 days.
About Accuray
Accuray Incorporated (ARAY), based in Sunnyvale, Calif., is the premier radiation oncology company that develops, manufactures and sells personalized, innovative treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The Company's leading-edge technologies – the CyberKnife and TomoTherapy Systems – are designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, and adaptive radiation therapy. To date, 642 systems have been installed in leading hospitals around the world. For more information, please visit www.accuray.com.
Available Topic Expert: For information on the listed expert, click appropriate link.
Euan Thomson, Ph.D.
ProfNet - https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=81869
Recent ARAY News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 08:40:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 01:00:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/06/2026 01:00:13 PM
- Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer • PR Newswire (US) • 04/06/2026 01:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 03/26/2026 07:05:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/19/2026 08:01:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 09:10:14 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/27/2026 09:11:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2026 09:10:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2026 09:10:06 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/17/2026 09:19:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 11:20:58 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 11:20:22 AM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 02/17/2026 11:18:45 AM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 02/17/2026 11:17:00 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/09/2026 09:10:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 09:08:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2026 09:05:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/04/2026 09:05:54 PM
- Accuray Reports Fiscal 2026 Second Quarter Financial Results • PR Newswire (US) • 02/04/2026 09:05:00 PM
- Accuray to Report Second Quarter Fiscal 2026 Financial Results on February 4, 2026 • PR Newswire (US) • 01/21/2026 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/20/2026 10:00:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2026 12:33:30 AM

